Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity

Table 1 Metabolic syndrome sets of criteria

2001 NCEP ATP III definition	AHA/NHLBI definition	IDF definition
(any three of five)	(any three of five)	(required ^a and any two of four criteria left)
BMI ≥30 kg/m²	BMI ≥ 30 kg/m²	BMI ≥30 kg/m^{2 a}
TG ≥150 mg/dl	TG ≥150 mg/dl or treatment for elevated TG	TG ≥150 mg/dl or treatment for elevated TG
C-HDL <40 mg/dl in men	C-HDL <40 mg/dl in men	C-HDL <40 mg/dl in men
C-HDL <50 mg/dl in women	C-HDL <50 mg/dl in women	C-HDL <50 mg/dl in women
Blood pressure ≥130/85 mmHg or previous hypertension diagnosis	Blood pressure ≥130/85 mmHg or previous hypertension diagnosis	Blood pressure ≥130/85 mmHg or previous hypertension diagnosis
Fasting glucose ≥110 mg/dl or previous type 2 DM	Fasting glucose ≥100 mg/dl or previous type 2 DM	Fasting glucose ≥100 mg/dl or previous type 2 DM

Criteria according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) definition [33], the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) definition [22] and the International Diabetes Federation (IDF) definition [34]. BMI, body mass index; C-HDL, high-density lipoprotein-cholesterol; DM, diabetes mellitus; TG, triglycerides.
^aIs a prerequisite risk factor for the MetS diagnosis.

ISSN: 1478-6362